Literature DB >> 19895620

Impact of substance use on the physical health of patients with bipolar disorder.

M P Garcia-Portilla1, P A Saiz, A Benabarre, G Florez, M T Bascaran, E M Díaz, M Bousoño, J Bobes.   

Abstract

OBJECTIVE: To describe the impact of tobacco, alcohol and cannabis on metabolic profile and cardiovascular risk in bipolar patients.
METHOD: Naturalistic, cross-sectional, multicenter Spanish study. Current use of tobacco, alcohol and cannabis was determined based on patient self-reports. Metabolic syndrome was defined using the National Health and Nutrition Examination Survey 1999-2000 and the American Heart Association/National Heart, Lung and Blood Institute criteria, and cardiovascular risk using the Framingham and the Systematic Coronary Risk Evaluation functions.
RESULTS: Mean age was 46.6 years, 49% were male. Substance use: 51% tobacco, 13% alcohol and 12.5% cannabis. Patients who reported consuming any substance were significantly younger and a higher proportion was male. After controlling for confounding factors, tobacco was a risk factor for coronary heart disease (CHD) (unstandardized linear regression coefficient 3.47, 95% confidence interval 1.85-5.10).
CONCLUSION: Substance use, mainly tobacco, was common in bipolar patients. Tobacco use negatively impacted CHD risk.

Entities:  

Mesh:

Year:  2009        PMID: 19895620     DOI: 10.1111/j.1600-0447.2009.01498.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  9 in total

1.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

2.  Seasonality, smoking and history of poor treatment compliance are strong predictors of dropout in a naturalistic 6 year follow-up of bipolar patients.

Authors:  Elena Ezquiaga; Aurelio García-López; Consuelo de Dios; Jose Luis Agud; David Albillo; Lorena Vega-Piris
Journal:  Psychiatr Q       Date:  2014-12

3.  Temporal sequencing of nicotine dependence and bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  José M Martínez-Ortega; Benjamin I Goldstein; Luis Gutiérrez-Rojas; Regina Sala; Shuai Wang; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2013-04-11       Impact factor: 4.791

4.  Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Susan J Wenze; Gary Epstein-Lubow; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2015-10-23       Impact factor: 3.735

5.  High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

Authors:  Virginio Salvi; Francesco Barone-Adesi; Virginia D'Ambrosio; Umberto Albert; Giuseppe Maina
Journal:  Psychopharmacology (Berl)       Date:  2015-09-26       Impact factor: 4.530

6.  Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness.

Authors:  I H Heiberg; R Nesvåg; L Balteskard; J G Bramness; C M Hultman; Ø Naess; T Reichborn-Kjennerud; E Ystrom; B K Jacobsen; A Høye
Journal:  Acta Psychiatr Scand       Date:  2020-02-29       Impact factor: 6.392

7.  Evolution of policy for the treatment of substance use disorders in Qatar.

Authors:  Majid Alabdulla; Nimesh Samarasinghe; Iain Tulley; Shuja Reagu
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-01-08

8.  Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.

Authors:  Maria Paz Garcia-Portilla; Leticia Garcia-Alvarez; Pilar Alejandra Saiz; Eva Diaz-Mesa; Gonzalo Galvan; Fernando Sarramea; Josefa Garcia-Blanco; Edorta Elizagarate; Julio Bobes
Journal:  Int J Environ Res Public Health       Date:  2013-12-24       Impact factor: 3.390

9.  Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder.

Authors:  Sarah Kittel-Schneider; Daniel Bury; Karolina Leopold; Sara Haack; Michael Bauer; Steffi Pfeiffer; Cathrin Sauer; Andrea Pfennig; Henry Völzke; Hans-Jörgen Grabe; Andreas Reif
Journal:  Front Psychiatry       Date:  2020-04-22       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.